PT-141

FDA Approved

Bremelanotide

Category
Sexual Health
Aliases
Bremelanotide, Vyleesi
Administration
Subcutaneous injection (approved), Intranasal (research)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Effects are typically felt within the same session, given the compound's fast onset — this window reflects the first several uses.

  2. 2

    3–4 Weeks

    Users generally know by now whether the compound produces a reliable effect for them.

  3. 3

    5–7 Weeks

    Regular users typically describe a consistent, predictable response with each use.

  4. 4

    8–10 Weeks

    No cumulative buildup is generally expected; effects remain tied to each individual dose.

  5. 5

    11–15 Weeks

    Consistent users often reassess dosing based on side effects like nausea experienced with continued use.

  6. 6

    16–20 Weeks

    Long-term users typically maintain a stable sense of what to expect from each dose.

  7. 7

    21–24 Weeks

    By this stage, most users have settled into a personal pattern of use based on their individual response.

⚠️ Research context only. This is not medical advice and results are not guaranteed.